Endocannabinoids are endogenous lipids that activate selective G protein coupled receptors (CB 1 and CB 2 ), mostly found at neuronal presynaptic sites in the nervous system. One of the main consequences of the activation of CB receptors is a decrease in GABA or glutamate release, controlling cell excitability. Here we studied the expression of CB 1 and CB 2 receptors in E8C8 cultured retina cells (embryonic day 8 and 8 days in vitro) using immunocytochemistry and western blot analysis. We also evaluated their functions in terms of cyclic AMP (cAMP) production, single cell calcium imaging (SCCI) and GABA release induced in basal conditions or activated by L-Aspartate (L-ASP) in cell cultures or under ischemia in young chick retina. We show that both cannabinoid receptors are expressed in retinal neurons and glial cells. WIN 55,212-2 (WIN, a CB 1 /CB 2 agonist) decreased cAMP production in cultured avian embryonic retinal cells in basal conditions. WIN also led to a decrease in the number of glial cells that increased Ca 2þ levels evoked by ATP, but had no effect in Ca 2þ shifts in neuronal cells activated by KCl. Finally, WIN inhibited [ 3 H]-GABA release induced by KCl or L-ASP, accumulated in amacrine cells, but had no effect in the amount of GABA released in an oxygen glucose deprivation (OGD) condition. Altogether, our data indicate that cannabinoid receptors function as regulators of avian retina signaling at critical embryonic stages during synapse formation.
Introduction
The endocannabinoid system (ECS) is present in most vertebrate species, distributed in several organs and tissues including the nervous system (Battista et al., 2012) . The two types of cannabinoid receptors CB 1 and CB 2 , are members of the G protein-coupled receptor (GPCR) family. These receptors are modulated by endogenous agonists, which are bioactive lipids produced on demand, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG), derived from phospholipids containing arachidonic acid (Iannotti et al., 2016) . A limited group of enzymes is responsible for the synthesis and degradation of these active lipids (Howlett, 2002) . In the central nervous system (CNS), ECS plays a central role in several types of synapses, as CB 1 are present mainly in the presynaptic neuron, acting as a regulatory mechanism for the release of several neurotransmitters such as glutamate or GABA (Katona and Freund, 2008) . Indeed, in the CNS, and particularly in the retina, it is common to observe the existence of cannabinoid receptors in postsynaptic terminals, thus indicating the complexity of the ECS in this tissue (Schwitzer et al., 2016) . It is also worth to mention that synthetic cannabinoids have the potential to be used as neuroprotective drugs to prevent and treat retinal diseases (Schwitzer et al., 2016) such as glaucoma. Nonetheless, it seems that in the avian retina, CB 1 and CB 2 are not involved with cell death described in the early stages of ischemia (Araujo et al., 2016) .
The main components of the ECS, such as cannabinoid receptors and endocannabinoid degrading enzymes are present in the vertebrate retina. Expression of CB 1 is detected predominantly in neurons found in different layers of the retina, as in horizontal, amacrine and ganglion cells Leonelli et al., 2005; Straiker et al., 1999) . On the other hand, CB 2 receptors once considered to be mainly expressed in the immune system, are now recognized to be expressed by many organs and tissues, including the retina (Lu et al., 2000) . Indeed, both cannabinoid receptors are found in Müller glia (Schwitzer et al., 2015) . However, despite being expressed almost in the same cells, it is suggested that modulation of CB 1 or CB 2 has different roles in the visual process . Therefore, different cannabinoid receptor ligands might modulate important signaling functions in the retina. Among these, one primary role deals with GABA and glutamate release by amacrine and bipolar cells, respectively (Wang et al., 2016) .
Neurons and glia cells interact mutually with each other in the vertebrate retina (de Melo Reis et al., 2008) , and the avian retina has been used as a model to study the role of neuro-and gliotransmitter in the last 40 years (Reis et al., 2007; Vergara and Canto-Soler, 2012) . We studied the expression and neurochemical regulation of cannabinoid receptors in retinal cells in normal condition or in oxygen-glucose deprivation (OGD). Here we show that CB receptors are highly expressed in neurons and glial cells in the avian retina modulating diverse aspects as transmitter release, cyclic AMP (cAMP) mobilization and Ca 2þ shifts that participate in the neuron-glia loop in the retina.
Material and methods
All experiments involving animals were approved and carried out in accordance with (i) the guidelines of the Institutional Animal Care and Use Committee of the Federal University of Rio de Janeiro (permit number IBCCF-035), (ii) the Ethics Committee for Animal Research of the CEPA/PROPPi, Fluminense Federal University (protocol number 197/2012), and (iii) with the guidelines of the Brazilian Society for Neuroscience and Behavior (SBNeC). In this study, we used around 40 fertilized white Leghorn chicken eggs (80 retinae). Embryos were staged according to (Hamburger and Hamilton, 1951) and sacrificed by decapitation on embryonic day 8 (E8). In order to evaluate endogenous GABA release or uptake, eyes were removed and the retinas of one-week post-hatched chicks were dissected out in a Ca 2þ -and Mg 2þ -free Hanks' (CMF) solution. We also used 8 animals, 16 retinas in a stage that the retina has already a mature configuration (Finnegan et al., 2008; Prada et al., 1991; Thanos and Mey, 2001 ). Dulbecco's modified Eagle's medium (DMEM), fetal calf serum (FCS) and gentamycin were obtained from Gibco (USA). [ 3 H]-GABA was from Amersham Pharmacia Biotech, Piscataway, NJ, USA. All other reagents were of analytical grade.
Retinal cells in culture
Mixed neuroneglial cells were prepared at a density of 20 Â 10 6 cells, while low-density cultures (enriched in neurons)
were at~2 Â 10 6 cells seeded on treated poly-L-lysine (10 mg/mL) obtained from 8 day's embryos and cultured for 8 days in vitro (E8C8) as described previously (Ventura et al., 2013) . Briefly, chick embryo (E8) retinas were dissected, cleared of pigmented epithelium and placed on a Ca 2þ -and Mg 2þ -free salt balanced medium (CMF). Trypsin (final concentration of 0.05% w/v) was added to the medium and incubated at 37 C for 10 min. After brief centrifugation, the pellet was suspended in 5 mL of DMEM þ F12 medium plus 5% fetal calf serum (FCS) and mechanically dissociated by pipetting the tissue. Cells were plated on 15 mm coverslips (Marienbad, German) previously treated with poly-L-lysine (to obtain neuronal enriched cultures, at 1% FCS). Alternatively, cells were plated in DMEM þ10% FCS to obtain enriched Müller glia cultures. The plates were then transferred to a humidified atmosphere of 95% air/5% CO 2 in an incubator. The medium was changed once 24 h after the cells were plated, and then at every 72 h.
Immunofluorescence
Retinal cells grown on 15 mm coverslips for 6e10 days were fixed for 15 min in paraformaldehyde (PFA, 4%) in 0.16 M PBS. Coverslips were washed three times with PBS and incubated for 30 min with 0.25% Triton X-100 in PBS (v/v) plus 3% donkey normal serum. Then, primary antibodies of interest [anti-CB 1 (anti-cannabinoid receptor 1 produced in goat -SAB2500190 from SigmaAldrich), dilution of 1:100, anti-CB 2 (anti-cannabinoid receptor 2 (M-15) produced in goat e sc-10076 from Santa Cruz Biotechnology) dilution of 1:100, anti-2M6 (mouse monoclonal, kindly provided by Dr. B. Schlosshauer; Max-Planck-Institute, Tübingen, Germany, (Schlosshauer et al., 1991) all produced from Thermo Fisher Scientific), all at the 1: 500 dilution were incubated for 2 h at room temperature in the dark. Finally, coverslips were examined in a fluorescence microscope (ApoTome 2 ® -ZEISS).
cAMP accumulation
Accumulation of cAMP was assayed according to the competitive binding assay as described previously (Kubrusly et al., 2005; Ventura et al., 2013) . Mixed neuron and glial cells in culture treated or not with 100 nM WIN were incubated for 30 min at 37 C in Basal Medium Eagle (BME) buffered with 20 mM HEPES at pH 7.3, containing 0.5 mM isobutyl-methylxanthine. The reaction was stopped by the addition of trichloroacetic acid to a final concentration of 5%, and the tissue was frozen immediately until further use. After centrifugation (15,000 rpm for 30 min), the supernatant was passed through an ion-exchange resin column (Dowex 50) to remove the trichloroacetic acid and other nucleotides. The samples containing cAMP were incubated in the presence of the regulatory subunit of PKA and a fixed trace amount of [ 3 H]-cAMP in 50 mM acetate buffer, pH 4.0, at 4 C for 90 min. The reaction was interrupted by addition of 200 mM phosphate buffer at pH 6.0. Samples were filtered through Millipore filters and the bound radioactivity determined in a liquid scintillation analyzer.
Western blot
Mixed neuron and glia cultures were washed twice in PBS (10 min each), homogenized and subjected to sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) as described before (Pohl-Guimaraes et al., 2010) . Protein concentration was estimated using the Bradford method (Bradford, 1976) . Samples were diluted in buffer composed of 10% glycerol (v/v), 1% b-mercaptoethanol, 3% SDS, and 62.5 mM Tris base and boiled for 5 min. Approximately 45 mg of protein from each sample were electrophoresed in 10% SDSePAGE and transferred to PDVF membranes (Millipore). Membranes were washed with Tween 20 Trisbuffered saline (TTBS) and blocked for 1.5 h with 5% non-fat milk in TTBS. Membranes were incubated with different antibodies; anti-CB 1 or anti-CB 2 (dilution used for each was 1:1000 in TTBS; Proteimax) overnight at 4 C. Membranes were rinsed in TTBS and incubated with anti-rabbit peroxidase conjugated secondary antibody (1:2000 in TTBS; Sigma-Aldrich) for 2 h at room temperature. Following three washes in TTBS (10 min each), labeling was detected with an ECL kit (Amersham). Blots were re-probed with anti-tubulin antibody (1:20000 in TTBS, Sigma-Aldrich) for 1 h at room temperature, rinsed in TTBS and incubated with anti-mouse peroxidase conjugated secondary antibody for 45 min at room temperature. Following three TTBS washes (10 min each), the labeling was detected with the ECL kit. Band intensities were analyzed by using Quantity One 4e6 software (Bio-Rad Laboratories Inc). (10 nM, 100 nM or 1 mM) were added for 15 min prior to the incubation period. The incubation medium was removed and the tissue was washed three times with 3 mL of cold Hank's 4 (128 mM NaCl, 4 mM KCl, 1 mM MgCl 2 , 3 mM CaCl 2 , 20 mM Hepes, 4 mM Glucose). This process was sufficient to wash the free radioactivity (not absorbed by the tissue). Then, 1 mL of water was added to disrupt cell membranes. Following repeated freeze-thaw cycles, cell radioactivity was assayed using a scintillation counter. Protein concentration was estimated by (Lowry et al., 1951) .
[

[ 3 H]-GABA release
The protocol was basically performed as previously described (Ferreira et al., 2014) . Briefly, mixed neuron and glial retinal cells were incubated with 1 mL DMEM containing 0.5 mCi [ 3 H]-GABA and 10 mМ of GABA (used as a carrier to improve the uptake) for 60 min at 37 C. Non-incorporated radioactive GABA was removed by successive washings with modified Hank's 4 solution (128 mM NaCl, 4 mM KCl, 1 mM MgCl 2 , 3 mM CaCl 2 , 20 mM Hepes, 4 mM Glucose). Then, cultures were superfused with 0.5 mL Hank's solution for 5 min at 37 C following a stimulus with 500 mM of L-ASP, 100 nM WIN 55,212-2, 1 mМ AM-251 (CB 1 receptor antagonist) or TRPV1 agonist, 1 mМ Capsaicin for 5 min. After the superfusion, radioactivity released in the medium was quantified by liquid scintillation. The remaining radioactivity in the cells was also counted after cell disruption with distilled water followed by successive freezeethaw cycles. The amount of radioactivity ([ 3 H]-GABA) released was plotted as the percentage of the total radioactivity taken up by the cells, and normalized by protein amount.
Single cell calcium imaging (SCCI)
Variations of free intracellular calcium levels ([Ca 2þ ]i) were evaluated in single cells obtained from retinal cells in culture adapting the protocol from (De Melo Reis et al., 2011) , essentially described in (Freitas et al., 2016) . Retinal cells in culture were loaded for 40 min with 5 mM Fura-2/AM (Molecular Probes), 0.1% fatty acid-free BSA, and 0.02% pluronic F-127 (Molecular Probes) in Krebs solution (132 mM NaCl, 4 mM KCl, 1.4 mM MgCl 2 , 2.5 mM CaCl 2 , 6 mM glucose, 10 mM HEPES, pH 7.4), in an incubator with 5% CO 2 and 95% atmospheric air at 37 C. After a 10-min postloading period at room temperature in Krebs solution, to obtain a complete hydrolysis of the probe, 15 mm coverslip (Marienbad, Germany) with cells was mounted on a chamber in a PH3 platform (Warner Instruments, Hamden, CT) on the stage of an inverted fluorescence microscope (Axiovert 200; Carl Zeiss). Cells were continuously perfused with Krebs solution and stimulated with standard solutions (50 mM KCl or 1 mM ATP). Solutions were added to the cells by a fast-transition system (4 s). The variations in [Ca 2þ ]i were evaluated by quantifying the ratio of the fluorescence emitted at 510 nm following alternate excitation (750 ms) at 340 and 380 nm, using a Lambda DG4 apparatus (Sutter Instrument, Novato, CA) and a 510 nm long-pass filter (Carl Zeiss) before fluorescence acquisition with a 20X objective and a Cool SNAP digital camera (Roper Scientific, Trenton, NJ). Acquired values were processed using the MetaFluor software (Universal Imaging Corp., West Chester, PA). Values for Fura-2 fluorescence ratio were calculated based on a cut-off of 15% increase in the [Ca 2þ ]i level induced by the stimulus. Cell cultures after SCCI were fixed in 4% PFA as described above.
Ex-vivo retinal stimulation of endogenous GABA release
The chick retina is relatively large and this allowed us to perform more experimental conditions using the same animal, for a review see (Vergara and Canto-Soler, 2012) . Chicks were killed and retinal pieces were obtained as previously described (Calaza et al., 2001; Guimaraes-Souza et al., 2011; Maggesissi et al., 2009) . Briefly, after enucleation, the posterior half of the eye containing the retina was used for the experiments. Each retina can be divided in up to four pieces. These retinal pieces were randomly assigned to the control condition or each experimental condition. Retinas were incubated in Locke's solution (157 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl 2 , 1 mM MgCl 2 , 3.6 mM Na 2 HCO 3 , 5.0 mM HEPES and 5.6 mM glucose) balanced with 95% O 2 /5% de CO 2 , and pH adjusted to 7.2e7.4 with HCl 1N and NaOH 1N. During the 30-min stimulation period, retinas were kept in a bath solution at 37 C with frequent shaking.
Retinal pieces were incubated in 500 mL of Locke's solution (control) or in the same solutions containing one or two of the following drugs for 20 min: 100 mM L-ASP or 1 mM WIN. To study whether WIN could inhibit L-ASP effect, retinal pieces were preincubated for 10 min with WIN and then incubated with L-ASP plus WIN together for more 30 min. The other experimental groups were also pre-incubated but in the Ringer solution only, without the drugs.
Oxygen and glucose deprivation
Retinal oxygen and glucose deprivation (OGD) for 30 min was used as a model of ischemia. To perform the experiments, normoxia condition comprised control medium (in mM: 120 NaCl; 3 KCl; 30 NaHCO 3 ; 1 NaH 2 PO 4 ; 1 CaCl 2 ; 1 MgCl 2 .6H 2 O; 10 glucose) saturated with 95%O 2 /5%CO 2 (White Martins Praxair Inc.). The ischemic condition (OGD) had the same medium composition as the control, except for the absence of glucose, and it was saturated with 95%N 2 / 5%CO 2 (White Martins Praxair Inc.). The pH of these solutions was adjusted to 7.2e7.4, and they were used immediately. To evaluate the effect of WIN (1 mM) during OGD, it was administered concomitant with OGD beginning. The non-ischemic retina (control) and the ischemic retina (OGD) were exposed to 95%O 2 /5%CO 2 (White Martins Praxair Inc.) or to 95%N 2 /5%CO 2 , respectively, during the whole procedure.
Data analysis
Unless specified otherwise, the results are expressed as mean ± standard error of the mean (SEM) of at least four separate experiments performed in triplicate. Statistical analysis was determined by Student's t-test or analysis of variance (ANOVA) followed by post-hoc Bonferroni test when necessary and statistical significance was taken at p < 0.05.
Results
Cannabinoid receptors expression pattern has been described in avian retinal sections from embryonic to adult chicks (Leonelli et al., 2005; Schwitzer et al., 2016) . In order to confirm the presence of CB receptors in avian retinal cells, neuron, glia-enriched or mixed neuron-glia cultured cells (Ventura et al., 2013) were prepared. As shown in Fig. 1 , both CB 1 and CB 2 receptors are expressed in mixed avian retinal cells in E8C8 cultures. CB 1 is expressed very early in the retina, around embryonic day 4 (E4) in the presumptive ganglion cell and inner nuclear layer (INL) (Leonelli et al., 2005) . To evaluate the presence of CB receptors in neuronal or glial cell types, immunocytochemistry was performed at low-density cultures enriched in neuron or glial cells and double stained with selective markers (2M6 for Müller and TUJ1 for neurons, Fig. 2 ) as well as for CB antibodies. Immunocytochemistry control, obtained by the omission of the primary antibody, shows no staining (not shown). CB 1 and CB 2 receptors are expressed in retinal neurons (Fig. 2 , cells labeled with TUJ1, green), as well as in Müller glial cells (Fig. 2 , cells stained with 2M6, green). Both CB 1 and CB 2 staining appears as dots over neurons as well as Müller cells (Fig. 2, inset) .
A classical activation of CB 1 /CB 2 receptors leads to the inhibition Fig. 1 . Expression of cannabinoid receptors in mixed neuron-glia cells in culture.
Representative immunoblots of CB 1 and CB 2 receptors. Membranes were prepared from mixed neuron-glia cultures at stage E8C8 were evaluated by Western blot analysis using specific primary antibodies (rabbit anti-CB 1 or CB 2 from Proteimax, Cotia, Brazil). Anti-CB 1 -specific antibody recognized a strong band with an apparent MW of 55 kDa, while anti-CB 2 recognized a band of 42 kDa. N ¼ 3 for each analysis. of adenylate cyclase (Vogel et al., 1993) . Therefore, in order to investigate whether cannabinoid receptors found in retinal cells are functional, WIN, a non-selective CB 1 /CB 2 agonist was added to investigate the accumulation of cAMP on avian mixed neuron-glial cells in culture. As shown, 100 nM WIN inhibited 52% the cAMP contents compared to basal levels (Fig. 3A) . It is known that GABA, the main inhibitory neurotransmitter is released by neurons and glial cells in mixed retina cell cultures or in purified Müller glia in culture (Ferreira et al., 2014; Freitas et al., 2016; Schitine et al., 2015) . As CB 1 receptors are mainly located at presynaptic sites (Katona et al., 1999) , we asked if activation of CB 1 / CB 2 receptors could lead to a decrease in [
3 H]-GABA release in basal condition. It has been demonstrated that retinal cell cultures (E8C8) used here present ribbon and non-ribbon synapses, corresponding respectively to photoreceptors/bipolar and amacrine cells (Combes et al., 1977) . As shown (Fig. 3B) (Fig. 3D) , an excitatory neurotransmitter found in the retina . It is known that GPCRs desensitize and are downregulated when chronically incubated with ligands, reviewed in (Rajagopal and Shenoy, 2017) . Therefore, we asked if a longer incubation (for 3 h) with WIN could interfere with cannabinoid receptor contents in retinal membranes from mixed neuronal and glial cells in culture. As expected, 100 nM WIN inhibited [ 3 H]-GABA release when incubated for 30 min, but had no effect when added for 3 h in cultured mixed neuron-glia retinal cells (Fig. 4A) . Therefore, we asked if the lack of effect of WIN 3 h later was due to a downregulation of CB receptors. Retinal membranes incubated with WIN were probed with anti-CB 1 or anti-CB 2 , and as shown, total protein levels demonstrate that 100 nM WIN after 3 h induced CB 1 , but not CB 2 downregulation ( Fig. 4B and C) as assessed through western blots. Previous reports have shown that WIN might also interact with the transient receptor potential vanilloid type 1 (TRPV 1 ) (Sampaio Fig. 4D ). In addition, capsaicin, a selective TRPV 1 agonist, had no effect on reducing GABA release as shown for WIN (Fig. 4E) , suggesting that CB 1 , but not TRPV 1 is mediating this effect (Basal 4.85 ± 0.19% of total; n ¼ 6; WIN 3.75 ± 0.16% of total; n ¼ 5; AM-251 þ WIN ± 0.12% of total; n ¼ 3; CAP þ WIN 3.3 ± 0.1% of total; n ¼ 3; p < 0.05). Therefore, our data suggest that a decrease in [ 3 H]-GABA release is mediated by CB 1 receptor activation. Cannabinoid receptors are known to modulate transmitter systems and to inhibit calcium currents, as reviewed in (Szabo and Schlicker, 2005) . In the retina, as well as in other areas in the nervous system, calcium shifts are activated in neurons by KCl (De Melo Reis et al., 2011; Freitas et al., 2016) , while ATP activates glial cells Freitas et al., 2016) . Therefore, we asked if WIN could alter the response of retinal neurons and glial cells in culture. Neurons are shown as group of bright cells with small cell bodies on top of Müller glia carpet on coverslips (Fig. 5A) . Fluorescent images illustrate cells loaded with 5 mM fura-2 and selected as region of interests (colored circles) (Fig. 5B) . Addition of 50 mM KCl induces calcium increase only in neurons (red traces), while 1 mM ATP activates solely Müller glia (green traces, Fig. 5C ). WIN had no effect when incubated for 30min (Fig. 5D ) in retinal cells activated by KCl or ATP (Bar graph in Fig. 5F ). However, WIN reduced the number of glia cells activated by ATP in terms of Ca 2þ shifts (Fig. 5E ), but not the number of neurons activated by KCl after 3 h (bar graph in Fig. 5G ). Taken together, our data show that a mixed CB 1 /CB 2 agonist modulates cAMP, Ca 2þ shifts in Müller cells and [
3 H] GABA release in basal conditions or stimulated by L-ASP. The great majority of cells in embryonic retinal cell cultures used in the present study are amacrine cells (Santos et al., 1998) . It has been demonstrated that mixed retinal cells in culture release GABA with the same mechanisms that operate on GABAergic amacrine cells from mature retina, through the reversal of GABA transporter (Calaza et al., 2001; do Nascimento and de Mello, 1985; Do Nascimento et al., 1998) . Therefore, even though the role of GABA during development and in mature retina can be different, it is interesting to evaluate whether the regulation mechanisms of GABA release are similar independent of maturation level of the tissue. Therefore, in order to verify whether activation of cannabinoid receptors controls GABA release in mature chick retina endogenous GABA release was studied by direct stimulation of post-hatched chick retinas, in an ex-vivo approach (Fig. 6) . As shown, amacrine cell bodies are heavily immunolabeled for GABA ]-GABA release promoted by WIN. Basal (4.85 ± 0.19% of total; n ¼ 6); WIN (3.75 ± 0.16% of total; n ¼ 5). AM-251 (4.2 ± 0.52% of total; n ¼ 3); AM-251 þ WIN (4.4 ± 0.12% of total; n ¼ 3); CAP (5.2 ± 0.36% of total; n ¼ 6). CAP þ WIN (3.3 ± 0.1% of total; n ¼ 3). P < 0.05. (Fig. 6A ), and after stimulation with 100 mM L-ASP for 30 min there was a notorious reduction of endogenous GABA content in the retinas (Fig. 6B ). This indicates a release of GABA from cells, as seen in retinal cell culture. Addition of 1 mM WIN completely blocked L-ASP effect on GABA availability (Fig. 6D) , but had no effect compared to basal levels (Fig. 6C) . Quantification shows that L-ASP reduced 30% the number of GABA-positive cells compared to control retinas (Fig. 6A, B and E) , and WIN totally inhibited L-ASPinduced GABA reduction in labeled cells (Control ¼ 100%; L-ASP ¼ 71.75 ± 3.85%, p > 0.05; L-ASP þ WIN ¼ 116.50 ± 8.77%, n ¼ 5) (Fig. 6E) . However, in the mature retina, the number of GABApositive cells in the INL did not significantly change in the presence of WIN (WIN ¼ 111.30 ± 8.54%, n ¼ 5) (Fig. 6C and E) suggesting that WIN does not control the release of basal GABA.
It is known that L-ASP is an excitatory neurotransmitter that acts selectively through NMDA receptor (Kubrusly et al., 1998; Yazulla and Kleinschmidt, 1983), which plays a major role in excitotoxicity or ischemic events. Moreover, it has already been reported that ionotropic glutamate receptor activation induces GABA release in the retina after an ischemic insult (Osborne and Herrera, 1994; Zeevalk and Nicklas, 1991) . Therefore, we wondered whether WIN could modulate endogenous GABA release in this pathological condition. There was a clear reduction of GABA-immunoreactivity in the mature avian retina after 30 min of OGD (Fig. 7B ) compared to control retinas (Fig. 7A) , indicating GABA release.
Nonetheless, addition of 1 mM WIN did not prevent the decrease of GABA-immunoreactivity induced by OGD (Fig. 7C) . The quantification confirmed a 55% reduction in the number of GABA-positive amacrine cells induced by OGD while addition of WIN had no effect compared to OGD condition (control ¼ 100.00%; OGD ¼ 45.20 ± 10.09%, n ¼ 3; OGD þ WIN ¼ 47.45 ± 2.85%, n ¼ 3; Fig. 7D ).
Discussion
Here we show that CB 1 and CB 2 receptors are expressed in both retinal neurons and Müller glia of chick embryos. Activation of CB 1 / CB 2 with WIN decreases cAMP levels, reduces Ca 2þ shifts in Müller glia activated by ATP and reduces [ 3 H]-GABA release in basal conditions or stimulated by L-ASP. These effects were observed in a stage were cells are fully active during synaptogenesis (Gleason and Wilson, 1989; Hughes and LaVelle, 1974; Reis et al., 2007) . In the CNS, neuronal CB 1 receptors are mainly located presynaptic, favoring control of excitatory and inhibitory transmitters release (Katona and Freund, 2008) . In addition, there is evidence that CB 1 is also found in post-synaptic sites (Chaves et al., 2008) . Cannabinoid receptors are critical regulators of transmitter release in the CNS, and in the retina, they are expressed since early stages of the embryonic stage (Leonelli et al., 2005; Schwitzer et al., 2016) . As they are involved in other brain areas with proliferation and differentiation (Bravo-Ferrer et al., 2017; Xapelli et al., 2013) , they could potentially drive generation of retinal cells and later operate on excitability of neuron-glia networks through glutamate and GABA release. These receptors have been found in the retina of many vertebrates, including monkey, mouse, chicken, tiger salamander and goldfish (Straiker et al., 1999) . Indeed, we found that CB 1 receptors are co-localized to synaptophysin, a pre-synaptic marker in the avian retina at embryonic stage E14, in the interplexiform layer (IPL) and ganglion cell layer (GCL), (data not shown), and it is known that at this period conventional synapses are already present in the IPL (Gleason and Wilson, 1989; Hering and Kroger, 1996) . It is important to mention that even though CB 1 modulates presynaptic glutamate or GABA, extra-synaptic GABA release has been reported to occur from amacrine cells in the mouse retina, counteracting the effects of glutamate released at the bipolar cell synapses (Hirasawa et al., 2015) . Although cannabinoid receptors might be coupled to G q or G s proteins or activate signaling pathway containing MAPK and ERK pathways , they classically stimulate G i proteins. Our results show that in the embryonic avian retinal cells, CB 1 and CB 2 receptors function most likely via activation of G i proteins with consequent reduction of the cAMP levels. Compelling evidence indicate that cAMP activated-pathways play an important role in retinal development (Guimaraes et al., 2001; Lankford et al., 1988) . Therefore, together with the widely CB 1 and CB 2 expression in neurons and glial cells showed in the present study and by others, reviewed in (Schwitzer et al., 2015 (Schwitzer et al., , 2016 , it is likely that cannabinoids, through the modulation of these intracellular pathways play a central role in retinal development. Much of the data available are from rodents and suggest 2-AG as an element involved in the regulation of the structural and functional maturation of the retina. 2-AG is found in early retinal development together with cannabinoid degrading enzymes DAGLa, present early in postnatal development and MAGL, appearing later during the development of the retina (Cecyre et al., 2014) . FAAH, the enzyme that degrades anandamide, is expressed at postnatal day 1 in ganglion and cholinergic amacrine cells (Zabouri et al., 2011) . Interestingly, FAAH is transiently expressed, suggesting a change in its redistribution during postnatal development and a role in developmental processes. The putative cannabinoid CB 3 receptor, GPR55, has also been shown to modulate the growth rate and target innervation of retinal projections in the mouse (Cherif et al., 2015) . Although the whole cannabinoid system has been described in the retina, there is no study evaluating the role of endocannabinoids, or their receptors, in the formation of synapses between retinal neurons. On the other hand, several studies have shown that cannabinoid system interfere with cone growth (Berghuis et al., 2007) , neurite growth (Jung et al., 2011; Williams et al., 2003; Zorina et al., 2010) , axon pathfinding (Watson et al., 2008) as well as synaptogenesis (Kim and Thayer, 2001 ) in other areas of CNS or cell lines. Finally, endocannabinoids and CB 1 agonists were shown to protect retinal amacrine neurons from AMPA excitotoxicity in vivo via a mechanism involving CB 1 receptors, through activation of PI3K/Akt and/or MEK/ERK1/2 signaling pathways (Kokona and Thermos, 2015) .
Addition of WIN for 3 h also promoted a reduction in the number of glial cells activated by ATP, but not of neuronal cells activated by KCl, in terms of Ca 2þ shifts (Fig. 5E, G) . Since our data implicate that CB 1 , but not CB 2 is downregulated in mixed retinal cells, we suggest that WIN is modulating Müller glia response in terms of Ca 2þ shifts most likely via CB 2 receptors (Fig. 4B) . Interestingly, CB 2 has been implicated with morphological changes at retinal growth cones in a PKA dependent manner in the mouse retina. This effect required the presence of the netrin-1 receptor, Deleted in Colorectal Cancer (Duff et al., 2013) . It is well characterized that endocannabinoids are important regulators of neurotransmitter release, especially GABA and glutamate, in the mature nervous system. However, only a few studies evaluated the role of cannabinoid receptors controlling GABA release during development, which are restricted to hippocampus and cerebellum (Bernard et al., 2005; Deshpande et al., 2011; Irving et al., 2000 (LoTurco et al., 1995) , cell cycle (Haydar et al., 2000) , maturation of cone photoreceptor (Schubert et al., 2010) , among others. In this sense, the fact that WIN controls GABA release in retinal neuron glia circuits seems to be crucial, particularly in the context of the discussion on the use of cannabinoids as therapeutic tools for several diseases. An epidemiological study estimated that 7.5e15% of all pregnant women contacting public and private prenatal facilities use illicit substances, and marijuana is one of the most frequently abused drugs (Adams et al., 1989) . There are a number of disturbances associated to marijuana exposure during fetal periods (Fried et al., 2003; Huizink and Mulder, 2006; Mereu et al., 2003; Zuckerman et al., 1989) . Therefore, it is very important to study the effects of cannabinoids in the development of retinal tissue. Another question raised in the present study was whether GABA release control by cannabinoids occurs only during development or it is conserved in the differentiated retina. To answer this question, we performed experiments with post-hatched chick retina. Thus, we observed that WIN has no effect on basal GABA release in the mature retina. However, it reduced GABA released from amacrine cells after L-ASP stimulation. So, WIN could be related to the control of amacrine feedback on activated-bipolar cells, and therefore with the indirect control of ganglion cells response. Although WIN might enhance [
3 H]-GABA release in the Globus pallidus, which depends on the limitation of G (i/o) protein availability (Gonzalez et al., 2009) , activation of cannabinoid receptors usually reduces neurotransmitter release on different CNS regions. Indeed, WIN reduces dose-dependently the release of GABA in different regions of the mature CNS, such as hippocampus, cerebellum, periaqueductal grey and striatonigral neurons (Katona et al., 1999; Takahashi and Linden, 2000; Vaughan et al., 2000; Wallmichrath and Szabo, 2002) . Therefore, the present study shows that cannabinoids control GABA release both in immature and differentiated retina. The regulation of GABA release evoked by L-ASP by cannabinoids, in avian retinal cells, could indicate a possible interaction between CB 1 or CB 2 and the NMDA receptors regulating GABA release via specific transporters. It has been described that the activation of CB 1 receptor reduces the NMDA receptor activity and attenuates its excitotoxicity due to an interference in NMDARregulated signaling pathways (Sanchez-Blazquez et al., 2014) . This opens a possibility on the use of cannabinoids or diet-based on polyunsaturated fatty acids (PUFA) that could lead to increase in endocannabinoid contents for therapeutical purposes (Freitas et al., 2017) . Currently, cannabis-based medication is used to treat spasticity in multiple sclerosis, anorexia, nausea, and neuropathic pain (Kaur et al., 2016) . Nonetheless, in the present study, we also demonstrated that WIN did not affect GABA release during ischemia. Therefore, cannabinoids control GABA release induced by NMDA receptor, in physiological condition, whereas during an ischemic episode these receptors were probably overwhelmed by a huge increase in glutamate availability as well as by the activation of all glutamate receptors. Thus, during acute ischemia cannabinoid receptors were not able to control GABA release, and probably neither glutamate release. This result was in accordance to a recent report showing that cannabinoid receptors have no protective role in the acute ischemia (Araujo et al., 2016) .
